Atlas Trials

Survival in Patients Older Than 60 Years With Newly Diagnosed AML in Spain

Clinical trial NCT03435341 · COMPLETED

Trial details

NCT number
NCT03435341
Sponsor
Celgene
Status
COMPLETED
Study type
OBSERVATIONAL
Leukemia, Myeloid, Acute
Start date
2018-02-28
Primary completion
2020-04-30
Enrollment
151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.